Improved Erythrocyte Deformability Induced by Sodium-Glucose Cotransporter 2 Inhibitors in Type 2 Diabetic Patients

被引：0
|
作者：
Minkook Son
Ye Sung Lee
A Ram Hong
Jee Hee Yoon
Hee Kyung Kim
Ho-Cheol Kang
Sung Yang
机构：
[1] Gwangju Institute of Science and Technology,Department of Biomedical Science and Engineering, School of Mechanical Engineering
[2] Gwangju Institute of Science and Technology,School of Mechanical Engineering
[3] Chonnam National University Medical School,Department of Internal Medicine
来源：
Cardiovascular Drugs and Therapy | 2022年 / 36卷
关键词：
SGLT-2 inhibitor; DPP-4 inhibitor; Hemorheology; Blood viscosity; Deformability; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：59 / 67
页数：8
相关论文
共 50 条
  • [21] Euglycemic Diabetic Ketoacidosis Secondary to Sodium-Glucose Cotransporter 2 Inhibitors
    Khaliq, M. F.
    Mohamed, H. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [22] Evolving Evidence of Diabetic Ketoacidosis in Patients Taking Sodium-Glucose Cotransporter 2 Inhibitors
    Fleming, Nicola
    Hamblin, Peter Shane
    Story, David
    Ekinci, Elif, I
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (08): : 2475 - 2486
  • [23] Postcardiac Surgery Euglycemic Diabetic Ketoacidosis in Patients on Sodium-Glucose Cotransporter 2 Inhibitors
    Auerbach, Jonathan S.
    Gershengorn, Hayley B.
    Aljure, Oscar D.
    Lamelas, Joseph
    Patel, Samira S.
    Ferreira, Tanira D.
    Gonzalez, Lazaro A.
    Cabrera, Jorge L.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2023, 37 (06) : 956 - 963
  • [24] Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Heart Failure: An Update
    Profili, Nicia I.
    Castelli, Roberto
    Gidaro, Antonio
    Manetti, Roberto
    Maioli, Margherita
    Delitala, Alessandro P.
    PHARMACEUTICALS, 2024, 17 (11)
  • [25] Sodium-Glucose Cotransporter 2 Inhibitors Improve Nocturnal Glucose Variability in Patients with Type 2 Diabetes
    Kakutani, Yoshinori
    Morioka, Tomoaki
    Ueda, Shuko
    Kawarabayashi, Reina
    Nakamura, Miyuki
    Asada, Mariko
    Yamazaki, Yuko
    Motoyama, Koka
    Mori, Katsuhito
    Shioi, Atsushi
    Shoji, Tetsuo
    Emoto, Masanori
    Inaba, Masaaki
    DIABETES, 2017, 66 : A240 - A240
  • [26] Elevated β-hydroxybutyric acid with no ketoacidosis in type 2 diabetic patients using sodium-glucose cotransporter-2 inhibitors
    Thapa, Simant Singh
    Lal, Amos
    Omer, Abdulkadir
    Trivedi, Nitin
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2019, 118 (10) : 1473 - 1474
  • [27] Sodium-Glucose Cotransporter 2 Inhibitors in Older Patients with CKD
    Bakker, Wisanne M.
    Gansevoort, Ron T.
    Yang, Changyuan
    Chertow, Glenn M.
    Heerspink, Hiddo J. L.
    Vart, Priya
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10): : 1446 - 1449
  • [28] Sodium-Glucose Cotransporter 2 Inhibitors and Amputations
    Clements, Jennifer N.
    JAMA INTERNAL MEDICINE, 2019, 179 (03) : 451 - 452
  • [29] Cardiovascular and Renal Benefit of Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes
    Lam, Steven Ho Man
    Alam, Uazman
    Lip, Gregory Yoke Hong
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 223 : 183 - 185
  • [30] Effects of Sodium-Glucose Cotransporter 2 Inhibitor on Carnitine Metabolism in Type 2 Diabetic Patients
    Harada, Marina
    Higa, Mariko
    Ohira, Akeo
    Kanaguchi, Momoko
    Miyashita, Naoko
    Doi, Ayano
    Yamashita, Kaoru
    Ouchi, Hiromi
    Ichijo, Takamasa
    DIABETES, 2016, 65 : A287 - A287
12345